Efficacy and tolerability of olanzapine, quetiapine, and risperidone in the treatment of early psychosis: A randomized, double-blind 52-week comparison
Joseph P. McEvoy, Jeffrey A. Lieberman, Diana O. Perkins, Robert M. Hamer, Hongbin Gu, Arthur Lazarus, Dennis Sweitzer, Christina Olexy, Peter Weiden, Stephen D. Strakowski
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Efficacy and tolerability of olanzapine, quetiapine, and risperidone in the treatment of early psychosis: A randomized, double-blind 52-week comparison'. Together they form a unique fingerprint.